Israel - English - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 533 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Israel - English - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 800 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Israel - English - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 800 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Israel - English - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 133 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Israel - English - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 133 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Israel - English - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 67 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Israel - English - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 67 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Israel - English - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - solution for injection - fentanyl as citrate 0.05 mg/ml - fentanyl - fentanyl - for analgesic action of short duration during anesthtic periods (premedication induction and maintenance) and in the immediate postoperative period as need arises. as a narcotic analgesic supplement in general or regional anesthesia. for administration with neuroleptics (such as droperidol) as an anesthetic premedication for the induction of anesthesia and as an adjunct in the maintenance of general or regional anesthesia. for use as an anesthetic agent with oxygen in selected high-risk patients (open heart surgery or certain neurological or orthopedic procedures). by the epidural route for the postoperative management of pain following general surgical procedures and cesarean sections and as adjunct to general anesthesia.

Israel - English - Ministry of Health

rafa laboratories ltd - oxycodone hydrochloride - syrup - oxycodone hydrochloride 10 mg / 5 ml - oxycodone - oxycodone - for use in the relief of moderate to severe pain.

Israel - English - Ministry of Health

rafa laboratories ltd - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - tablets prolonged release - oxycodone hydrochloride 10 mg; naloxone hydrochloride (as dihydrate) 5 mg - naloxone - naloxone - targin is indicated for the relief of moderate to severe pain.the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.